164. Bevacizumab Suppresses Neuroblastoma Progression in the Setting of Minimal Residual Disease
Thomas L. Sims Jr., J. Blair B. Hamner, Cathy Ng, Shannon F. Rosati, Yunyu H. Spence, Regan F. Williams, Andrew M. DavidoffVolume:
144
Year:
2008
Language:
english
DOI:
10.1016/j.jss.2007.12.187
File:
PDF, 49 KB
english, 2008